Anavex Life Sciences AVXL
As further described under Item 5.07 of this Current Report on Form 8-K
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001731122-26-001294
- Reports a change in control (5.01)
- Reports shareholder vote results (5.07)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.
- ImmunityBio IBRX public float $690M, Jun 30, 2025
- LENZ Therapeutics LENZ public float $690M, Jun 30, 2025
- Vir Biotechnology VIR public float $689M, Jun 30, 2025
- Relay Therapeutics RLAY public float $586M, Jun 30, 2025
- Ginkgo Bioworks Holdings DNA public float $553M, Jun 28, 2025